RTW INVESTMENTS, LP

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1493215 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$61,150,708

-$29,039,925 QoQ

Shares Held

13,680,248

-16.6% QoQ

Ownership

4.76%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RTW INVESTMENTS, LP holds $8,256,157,304 across 64 Biotechnology names. TSHA ranks #30 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	1,993,687	$1,043,635,333
2	INSM	INSMED Inc	4,842,880	$791,907,737
3	PTGX	Protagonist Therapeutics, Inc	5,059,053	$533,224,186
4	PTCT	Ptc Therapeutics, Inc.	7,746,415	$527,763,253
5	ARGX	Argenx SE	709,446	$518,072,941
6	CGON	CG Oncology, Inc.	6,984,808	$472,731,805
7	CELC	Celcuity Inc.	3,039,621	$346,942,340
8	TNGX	Tango Therapeutics, Inc.	13,300,620	$278,248,970

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$61,150,708	13,680,248	-16.6%	Shares	Sole	2026-05-15
2025-12-31	$90,190,633	16,398,297	-32.7%	Shares	Sole	2026-02-17
2025-09-30	$79,638,531	24,354,291	-2.7%	Shares	Sole	2025-11-14
2025-06-30	$57,799,859	25,021,584	+33.2%	Shares	Sole	2025-08-14
2025-03-31	$26,115,133	18,787,866	+116.6%	Shares	Sole	2025-05-15
2024-12-31	$15,003,649	8,672,630	-42.0%	Shares	Sole	2025-02-14
2024-09-30	$30,042,304	14,946,420	-20.5%	Shares	Sole	2024-11-14
2024-06-30	$42,112,669	18,800,299	+1.1%	Shares	Sole	2024-08-14
2024-03-31	$53,362,440	18,593,185	+10.1%	Shares	Sole	2024-05-15
2023-12-31	$29,900,937	16,893,185	0.0%	Shares	Sole	2024-02-14
2023-09-30	$53,382,464	16,893,185	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.